Targeting interleukins for the treatment of inflammatory bowel disease: What lies beyond anti-TNF therapy?

Mairi H. McLean*, Markus F. Neurath, Scott K. Durum

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

39 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Targeting interleukins for the treatment of inflammatory bowel disease: What lies beyond anti-TNF therapy?'. Together they form a unique fingerprint.

Medicine & Life Sciences